Navigation Links
Centocor Ortho Biotech Inc. Awarded $1.67 Billion Patent Jury Verdict from Abbott Laboratories
Date:6/29/2009

HORSHAM, Pa., June 29 /PRNewswire/ -- Centocor Ortho Biotech Inc. announced today that a federal jury has returned a verdict of $1.67 billion against Abbott Laboratories in a patent infringement suit.

"We are pleased that the jury has ruled in our favor in the patent litigation case against Abbott," said Kim Taylor, President, Centocor Ortho Biotech Inc. The patent in question relates to the company's anti-TNF class of arthritis treatments, and is co-owned by New York University and Centocor, for which Centocor is the exclusive licensee.

"We are particularly gratified that the jury recognized our valuable intellectual property, finding our patent both valid and infringed. We will continue to assert intellectual property rights for our immunology therapies, as they offer significant advances in treatment for patients with a number of immune mediated inflammatory diseases," Taylor added.

About Centocor Ortho Biotech Inc.

Centocor Ortho Biotech Inc. redefines the standard of care in immunology, nephrology, and oncology. The company was created when Ortho Biotech Inc. merged into Centocor, Inc., and Centocor, Inc. was renamed Centocor Ortho Biotech Inc. Built upon a pioneering history, Centocor Ortho Biotech Inc. harnesses innovations in large-molecule and small-molecule research to create important new therapeutic options. Beyond its innovative medicines, Centocor Ortho Biotech is at the forefront of developing education and public policy initiatives to ensure patients and their families, caregivers, advocates, and healthcare professionals have access to the latest treatment information, support services, and quality care. For more information about Centocor Ortho Biotech, visit www.CentocorOrthoBiotech.com. Centocor Ortho Biotech is a wholly-owned subsidiary of Johnson & Johnson.

This
'/>"/>

SOURCE Centocor Ortho Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
2. Baseline Research Indicates High Interest in Centocor-Ortho Biotechs SIMPONI(R)
3. GeneNews provides Centocor access to its osteoarthritis program
4. Ortho Biotech, L.P. and Centocor, Inc. Alert Authorized Distributors and Prescribing Physicians About Stolen Product
5. Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
6. Centocor/Janssen-Cilags Ustekinumab Will Become the Gold Standard for Psoriasis By 2011
7. Centocor Announces Ustekinumab Biologic License Application Accepted for Filing by FDA
8. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
9. Orthocrat Announces Successful Implementation of TraumaCad at UPMC Mercy
10. Frost & Sullivan Recognizes ApaTechs Leadership in Orthopedic Biologics
11. Pioneer(R) Surgical Technology, Inc. Wins Frost & Sullivans 2009 North American Orthopaedic Tissue Engineering Technology Innovation Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... A recent study from researchers in ... find that those who took probiotics were able to run ... study showed that in extreme heat conditions, probiotics were able ... acne treatment explains what this new discovery means ... their skin condition. , While researchers tote the benefits ...
(Date:5/21/2013)... PALM BEACH, Fla. , May 21, 2013 ... (NYSE: FCN ), the global business ... enhance their enterprise value (the "Company"), announced that ... focused personnel that were formerly included within the ... and Litigation Consulting segment to form a single ...
(Date:5/21/2013)... study led by George Washington University Professor Tianshu ... ice in small droplets is strongly size-dependent, an ... nanoscale. The formation of ice at the nanoscale ... answer also has important implications for climate research ... ice from supercooled water is generally initiated by ...
(Date:5/21/2013)... Clinverse, Inc. , a global ... announced today it has formed a strategic alliance ... FLS eClinical commerce platform aggregates data collected through ... ™, Aggregate Spend Solutions’ recently-launched flagship product, is ... transfer of value at investigator meetings or any ...
Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice 2Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3
... of the 96 Core Curriculum Sessions Include Presentations from ... Committed to Magnetic Navigation Stereotaxis to Feature New Odyssey ... Generation Software Products in ... announced today that its participation at Heart Rhythm 2008 reflects,the broad ...
... OXFORD, England, May 9 ,EUSA Pharma Inc (,EUSA,), ... control and critical care, today announced that,it has ... of Cytogen,s shareholders at a special meeting on ... acquisition agreement, Cytogen shareholders will,receive $0.62 per share, ...
... for robust growth -, - Includes proprietary adult stem cell bone graft product and ... ... million in 2009; no dilution to earnings per share in 2008 or 2009, ... in-process R&D charge -, SAN ...
Cached Biology Technology:Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2008 2Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2008 3Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2008 4Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2008 5EUSA Pharma Completes Acquisition Of Cytogen Corporation 2EUSA Pharma Completes Acquisition Of Cytogen Corporation 3NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics 2NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics 3NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics 4NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics 5NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics 6
(Date:5/22/2013)... (May 22, 2013)The omega 3 fatty acids in fish ... diseaseso much so that the American Heart Association currently ... week, particularly fatty varieties rich in omega 3s. However, ... mystery. In a new study, scientists led by Jason ... this phenomenon by providing evidence that fish oil might ...
(Date:5/22/2013)... important new details on how climate change will affect ... in the Journal of Animal Ecology . This ... and informing policymakers of how species are likely to ... is a growing recognition among biologists that climate change ... that this is going to have very important consequences ...
(Date:5/21/2013)... "patient monitoring" device attached to a whale entangled in ... fishing lines changed a whale,s diving and swimming behavior. ... to eat and migrate, depletes their energy as they ... in a slow death. , The scientists in this ... to a two-year-old female North Atlantic right whale called ...
Breaking Biology News(10 mins):Fish oil may help the heart beat mental stress 2UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5Study reveals how fishing gear can cause slow death of whales 2Study reveals how fishing gear can cause slow death of whales 3
... GROVE, Ill., Nov. 6 Secure Services Corp.,(SSC), ... information and,communication has achieved a milestone within the ... and Privacy Environment (SHAPE),Smart Token(R) Constructive Key Management ... credential management platform. SSC is one of,the first ...
... rise, coastal communities could lose up to 50 percent more ... a new study from Ohio State University. Hydrologists here ... given the sea level rise predicted by the Intergovernmental Panel ... the next 100 years, sea level could rise as much ...
... Fitting a key into a lock may seem like a ... a method that involves testing thousands of keys to unlock ... door for new targets for drug designs. Texas A&M ... who modified a technique called molecular docking to predict which ...
Cached Biology News:Secure Services Corp. Achieves Milestone in United States Identity Protection with the Launch of the SSC SHAPE Card Management Solution 2Secure Services Corp. Achieves Milestone in United States Identity Protection with the Launch of the SSC SHAPE Card Management Solution 3Secure Services Corp. Achieves Milestone in United States Identity Protection with the Launch of the SSC SHAPE Card Management Solution 4Climate change could diminish drinking water more than expected 2Climate change could diminish drinking water more than expected 3Unlocking the function of enzymes 2
... and M.W. Turner (1997). • This ... used in the production of high-quality ... immunoassays, the standardisation of antibodies and ... amplification systems, enzyme immunoassays for detecting ...
... MW: 34.2kDa Formulation: 10mM HEPES, pH ... dithiothreitiol with 50% glycerol Properites: For ... Certificate of Analysis for individual lots ... followed by gel filtration and Mono-S ...
MitoScreen (JC-1) Kit , 100 tests Consult technical datasheet for details....
Thermal Printer Paper for Monolight(tm) Luminometer 1 each...
Biology Products: